Key Findings:  Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome related diseases, Parkinson's disease, Huntington's Disease, Alzheimer's Disease and Tourette's Syndrome could possibly be treated by drugs modulating endocannabinoid system.
Type of Study:  Meta-analysis
Study Result:  Positive
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), SR-x Synthetic Cannabinoids, Cannabinoid (unspecified), Synthetic Cannabinoid (unspecified), Pharma THC, Pharma THC:CBD
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype I, Chemotype II